Literature DB >> 19303138

Adjuvant imatinib in GIST: a self-fulfilling prophecy, or more?

Peter Hohenberger1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19303138     DOI： 10.1016/S0140-6736(09)60562-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Cyclin H expression is increased in GIST with very-high risk of malignancy.

Authors:  Julian Dorn; Hanno Spatz; Michael Schmieder; Thomas Fe Barth; Annette Blatz; Doris Henne-Bruns; Uwe Knippschild; Klaus Kramer
Journal:  BMC Cancer       Date:  2010-07-02       Impact factor: 4.430

2.  Prediction of Tumor Recurrence in Patients with Non-Gastric Gastrointestinal Stromal Tumors Following Resection according to the Modified National Institutes of Health Criteria.

Authors:  Seung Hyeon Jang; Ji Eun Kwon; Jee Hyun Kim; June Young Lee; Sang Gyun Kim; Joo Sung Kim; Hyun Chae Jung; Jong Pil Im
Journal:  Intest Res       Date:  2014-07-25

3.  KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors.

Authors:  Senyan Lai; Guihua Wang; Xiaonian Cao; Xuelai Luo; Guoping Wang; Xianmin Xia; Junbo Hu; Jing Wang
Journal:  Oncotarget       Date:  2016-01-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.